News

News

World Bank rejects IP waiver as WTO talks resume

09 Jun 2021

 

Major vaccine makers and the pharmaceutical industries have opposed the waiver from the WTO’s agreement on Trade-Related Aspects of Intellectual Property Rights (Trips), arguing that it would stifle innovation and do little to effectively increase vaccine supplies constrained by trade barriers, shortages of components and a lack of manufacturing capabilities.

 

[BACK TO NEWS]